MHC class I manipulation on cell surfaces by gene transfer of anti-MHC class I intrabodies - a tool for decreased immunogenicity of allogeneic tissue and cell transplants

被引:19
|
作者
Busch, A
Marasco, WA
Doebis, C
Volk, HD
Seifert, M
机构
[1] Humboldt Univ, Sch Med, Dept Med Immunol, D-10098 Berlin, Germany
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
关键词
intrabodies; antibodies intracellular; major histocompatibility antigen class I; tissue engineering; transfection; fusionprotein; bicistronic expression;
D O I
10.1016/j.ymeth.2004.03.017
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Intrabodies (IB) are suitable tools to down-regulate the expression of cell surface molecules in general. In this work, the appearance of major histocompatibility (MHC) class I molecules on the cell surface could be prevented by the expression of intracellularly localized anti-MHC class I antibodies. The expression of MHC antigens presenting intracellularly synthetised peptides on the cell surface is the predominant reason for immunologic detection and rejection of allogeneic cell and tissue transplants. Allogeneic keratinocyte sheets might be a suitable tool for skin grafting. Within this study primary rat keratinocytes have been transfected with anti-MHC I-IB. Strong IB-expressing cells showed a MHC I "knockout" phenotype. The cells did not exhibit any significant alterations compared to non-transfected cells: the cell growth and the expression of other surface molecules were unaltered. Merely an enhanced intracellular accumulation of MHC I molecules could be detected. Notably, IB-expressing keratinocytes displayed a reduced susceptibility to allogeneic cytotoxic T cells in vitro compared to unmodified cells with a normal level of MHC I surface expression. These MHC I-deficient keratinocytes might be utilized in tissue-engineered allogeneic non-immunogeneic skin transplants. The principle of MHC class I manipulation in general can be used for other allogeneic cell and tissue-engineered transplants as well. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:240 / 249
页数:10
相关论文
共 50 条
  • [21] Natural killer cell receptors and MHC class I interactions
    Lanier, LL
    CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) : 126 - 131
  • [22] Beta cell MHC class I is a late requirement for diabetes
    Hamilton-Williams, EE
    Palmer, SE
    Charlton, B
    Slattery, RM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) : 6688 - 6693
  • [23] NATURAL-KILLER-CELL INTERACTION WITH MURINE ALLOGENEIC MHC CLASS-I MOLECULES
    SALCEDO, M
    HOGLUND, P
    LJUNGGREN, HG
    TRANSPLANTATION, 1995, 60 (03) : 281 - 286
  • [24] Alloreactive T cell recognition of MHC class I molecules - The T cell receptor interacts with limited regions of the MHC class I long alpha helices
    Smith, KD
    Lutz, CT
    JOURNAL OF IMMUNOLOGY, 1997, 158 (06): : 2805 - 2812
  • [25] Transduction of MHC-class I negative allogeneic cell line to improve the efficacy of anti-tumor vaccination
    Curti, A
    Colombo, MP
    Baccarani, M
    Lemoli, RM
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2002, 16 (03): : 236 - 240
  • [26] Therapeutic effect of Anti-MHC class I mAb, RE2 on hepatitis and atopic dermatitis
    Matsuoka, S.
    Tsurui, H.
    Obulhasim, G.
    Zhang, N. Li D.
    Sun, GD.
    Kobayashi, K.
    Kajino, K.
    Hino, O.
    13TH INTERNATIONAL CONGRESS OF IMMUNOLOGY, 2007, : 285 - +
  • [27] Renal Fibroblast Activation and Survival by Anti-MHC Class I Antibody: The Role of mTOR Signaling Pathway
    Chen, J.
    Zmijewska, A.
    Mannon, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 407 - 407
  • [28] Host MHC class I gene control of NK-cell specificity in the mouse
    Hoglund, P
    Sundback, J
    OlssonAlheim, MY
    Johansson, M
    Salcedo, M
    Ohlen, C
    Ljunggren, HG
    Sentman, CL
    Karre, K
    IMMUNOLOGICAL REVIEWS, 1997, 155 : 11 - 28
  • [29] The PML gene is not involved in the regulation of MHC class I expression in human cell lines
    Bruno, S
    Ghiotto, F
    Fais, F
    Fagioli, M
    Luzi, L
    Pelicci, PG
    Grossi, CE
    Ciccone, E
    BLOOD, 2003, 101 (09) : 3514 - 3519
  • [30] Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy
    Bagley, J
    Tian, CR
    Sachs, DH
    Iacomini, J
    BLOOD, 2002, 99 (12) : 4394 - 4399